We are live on ! Find out more
VFA

Virtus Fund Advisers Portfolio holdings

AUM $32.1M
1-Year Est. Return 39.5%
This Fund
S&P 500
This Quarter Est. Return
+4.21%
1 Year Est. Return
+39.5%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$14.3M
AUM Growth
+$310K
Cap. Flow
-$20K
Cap. Flow %
-0.14%
Top 10 Hldgs %
65.27%
Holding
116
New
18
Increased
–
Reduced
9
Closed
11

Top Buys

Rank Stock Value
1
INTA icon
Intapp
INTA
+$113K
2
CDMO
Avid Bioservices, Inc. Common Stock
CDMO
+$54.7K
3
SLCA
U.S. SILICA HOLDINGS, INC.
SLCA
+$51.9K
4
ZETA icon
Zeta Global
ZETA
+$45.9K
5
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
+$33.2K

Top Sells

Rank Stock Value
1
BCPC
Balchem Corp
BCPC
+$70.6K
2
ALHC icon
Alignment Healthcare
ALHC
+$65.4K
3
RHP icon
Ryman Hospitality Properties
RHP
+$61.2K
4
CMC icon
Commercial Metals
CMC
+$58.4K
5
CATY icon
Cathay General Bancorp
CATY
+$47.2K

Sector Composition

Rank Sector Weight
1 Financials 21.24%
2 Energy 13.36%
3 Consumer Discretionary 13.01%
4 Materials 11.61%
5 Technology 10.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CYTK icon
101
Cytokinetics
CYTK
$10.8B
$19.4K 0.14%
550
-373
-40% -$15.2K
CPRX
102
DELISTED
Catalyst Pharmaceutical
CPRX
$17K 0.12%
+1,028
New +$17K
BEAM icon
103
Beam Therapeutics
BEAM
$2.76B
$14.3K 0.1%
+467
New +$18.4K
AMRX icon
104
Amneal Pharmaceuticals
AMRX
$6.11B
$9.65K 0.07%
+6,941
New +$13.8K
SD icon
105
SandRidge Energy
SD
$502M
$2.71K 0.02%
159
– –
ALHC icon
106
Alignment Healthcare
ALHC
$3.77B
– –
-5,565
Closed -$65.4K
BCRX icon
107
BioCryst Pharmaceuticals
BCRX
$2.46B
– –
-1,900
Closed -$21.8K
CATY icon
108
Cathay General Bancorp
CATY
$4.24B
– –
-1,156
Closed -$47.2K
INSM icon
109
Insmed
INSM
$22.6B
– –
-1,438
Closed -$28.7K
OMCL icon
110
Omnicell
OMCL
$2.01B
– –
-256
Closed -$12.9K
RHP icon
111
Ryman Hospitality Properties
RHP
$8.62B
– –
-748
Closed -$61.2K
SAIC icon
112
Saic
SAIC
$4.96B
– –
-298
Closed -$33.1K
BCPC
113
Balchem Corp
BCPC
$5.27B
– –
-578
Closed -$70.6K
ISEE
114
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
– –
-1,305
Closed -$27.9K
LHCG
115
DELISTED
LHC Group LLC
LHCG
– –
-151
Closed -$24.4K
VIVO
116
DELISTED
Meridian Bioscience Inc
VIVO
– –
-776
Closed -$25.8K
1 2 3 4
5

Similar funds

VCM
V3 Capital Management Dallas, Texas $33.4M AUM 5.9% 1-Year Est. Return
CGI
Calixto Global Investors Coral Gables, Florida $30.7M AUM 111.27% 1-Year Est. Return
SFM
Spartan Fund Management Toronto, Ontario, Canada $30M AUM 11.98% 1-Year Est. Return
CIA
Compass Investment Advisers Portland, Oregon $34.4M AUM
SL
Stevard LLC Chicago, Illinois $26.8M AUM 42.43% 1-Year Est. Return
OAM
Origin Asset Management London, United Kingdom $43.5M AUM 31.63% 1-Year Est. Return
MFAM
M Financial Asset Management Portland, Oregon $20.6M AUM 4.99% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return

Virtus Fund Advisers's Q1 2023 Portfolio in Review

As of Q1 2023, Virtus Fund Advisers held 116 positions worth $14.3M, up 2.2% from $13.9M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Virtus Fund Advisers's Q1 2023 filing shows 18 new, 9 reduced and 11 closed positions. Its largest new stake was Intapp: 3,207 shares worth $144K. The largest sale was Balchem Corp, an estimated $70.6K.

By sector, the portfolio is most concentrated in Financials at 21% of assets, down from 22% a quarter earlier, followed by Energy and Consumer Discretionary.

  • Virtus Fund Advisers's largest Q1 2023 buy was Intapp: 3,207 shares worth $144K.
  • Virtus Fund Advisers's biggest Q1 2023 reduction was Commercial Metals, cutting an estimated $58.4K.
  • Virtus Fund Advisers fully exited Balchem Corp in Q1 2023, selling an estimated $70.6K.
  • Virtus Fund Advisers's ten largest holdings make up 65% of its $14.3M portfolio in Q1 2023.
  • Virtus Fund Advisers opened 18 new positions and closed 11 in Q1 2023.
  • Virtus Fund Advisers's portfolio value rose 2.2% quarter-over-quarter to $14.3M.

Based on Virtus Fund Advisers's 13F filing for Q1 2023, filed 15 May 2023.